Library / Laws / 118th Congress / Senate Bills / S. 2454
S. 2454
To require reports on and investments in pharmaceutical supply chain resiliency to reduce reliance on the People’s Republic of China for finished pharmaceutical products and active pharmaceutical ingredients.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2023-08-05 | 5.3K | ⠃⠗⠋ |